| Catalog No. | VK565160 |
| Host species | Human |
| Species reactivity | SARS-CoV-2 (2019-nCoV) |
| Form | Liquid |
| Storage buffer | 0.01M PBS, pH 7.4. |
| Purity | >95% as determined by SDS-PAGE. |
| Clonality | Monoclonal |
| Isotype | IgG1, kappa |
| Applications | ELISA, Neutralization |
| Target | Spike glycoprotein, S glycoprotein, E2, Peplomer protein, RBD, Spike protein S1, S, Receptor-Binding Domain, RBD (KP.2) |
| Purification | Protein A/G purified from cell culture supernatant. |
| Endotoxin level | Please contact with the lab for this information. |
| Accession | P0DTC2 |
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term. |
| Clone ID | Iv0263 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| RRID | InVivoMAb Anti-SARS-CoV-2 RBD (KP.2) Neutralizing Antibody (Iv0263) (abinScience Cat# VK565160, RRID:AB_3729615) |
InVivoMAb Anti-SARS-CoV-2 RBD (KP.2) Neutralizing Antibody (Iv0263)
Overview
Description
InVivoMAb Anti-SARS-CoV-2 RBD (KP.2) Neutralizing Antibody (Iv0263) [Iv0263] (VK565160) is a human monoclonal antibody detecting Spike glycoprotein in ELISA, Neutralization.
Images
 SDS-PAGE |
SDS-PAGE for InVivoMAb Anti-SARS-CoV-2 RBD (KP.2) Neutralizing Antibody (Iv0263) |